Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-26 Sale | 2026-02-27 7:00 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 25,000 | $161.11 | $4,027,750 | 450,996 (Indirect Direct) | View |
| 2025-09-08 Purchase | 2025-09-09 8:11 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 1,575 | $127.28 | $200,466 | 452,068 (Indirect Direct) | View |
| 2025-05-27 Sale | 2025-05-29 7:00 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 7,500 | $104.45 | $783,375 | 450,493 (Indirect Direct) | View |
| 2025-05-20 Sale | 2025-05-20 9:46 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 3,000 | $107.49 | $322,473 | 457,993 (Indirect Direct) | View |
| 2024-05-28 Sale | 2024-05-29 8:11 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 10,497 | $75.17 | $789,107 | 14,600 (Direct) | View |
| 2023-09-15 Sale | 2023-09-15 6:30 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 29,588 | $75.18 | $2,224,430 | 428,953 (Indirect Direct) | View |
| 2021-11-18 Purchase | 2021-11-22 07:30 am | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 1,430 | $35.09 | $50,181 | 426,528 (Indirect Direct) | View |
| 2021-05-12 Purchase | 2021-05-13 07:05 am | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 500 | $58.15 | $29,075 | 425,098 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-23 Exercise | 2026-02-25 7:00 pm | 2018-03-15 2027-03-15 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 6,250 | $0 | 483,717 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 6,250 | $4.95 | 483,717 (Direct) | View |
| 2026-02-20 Exercise | 2026-02-23 7:23 pm | 2018-03-15 2027-03-15 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 12,485 | $0 | 483,717 (Direct) | View |
| 2026-02-20 Exercise | 2026-02-23 7:23 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 12,485 | $4.95 | 483,717 (Direct) | View |
| 2026-02-10 Exercise | 2026-02-10 7:11 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 5,193 | $0 | 457,261 (Direct) | View |
| 2026-02-10 Exercise | 2026-02-10 7:11 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 5,193 | $8.02 | 457,261 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 4,595 | $0 | 4,595 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 4:06 pm | 2016-11-19 2025-11-19 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 9,127 | $0 | 460,993 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 4:06 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 9,127 | $9 | 460,993 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-20 4:30 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 33,410 | $5.94 | 451,866 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-20 4:30 pm | 2015-06-29 2025-06-29 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 33,410 | $0 | 451,866 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 4:31 pm | 2025-06-07 2034-06-07 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 5,799 | $0 | 5,799 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-15 6:30 pm | 2015-09-16 2024-09-16 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 11,016 | $0 | 428,953 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-15 6:30 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 11,016 | $3.67 | 428,953 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 6:21 pm | 2024-06-02 2033-06-02 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 5,681 | $0 | 5,681 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:13 pm | 2023-03-02 2033-03-01 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 2,870 | $0 | 2,870 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-04 4:11 pm | 2013-03-22 2023-03-21 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 17,501 | $0 | 447,525 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-04 4:11 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 17,501 | $1.3 | 447,525 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:07 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-03-15 Exercise | 2022-03-17 07:05 am | 2013-03-22 2023-03-21 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 3,496 | $0 | 447,525 (Direct) | View |
| 2022-03-15 Exercise | 2022-03-17 07:05 am | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 3,496 | $1.3 | 447,525 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 2,798 | $0 | 2,798 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:51 pm | 2022-06-04 2031-06-04 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 7,325 | $0 | 7,325 (Direct) | View |